Logistics struggle of Dr Reddy’s to launch a generic drug in Europe amid lockdownLogYcode
Drug maker Dr Reddy’s speak about how their distribution department failed to deliver a generic product in Europe in the wake of the Covid-19 pandemic and global lockout.
“The launch of an important generic medicine in Europe ran into the danger to be significantly delayed, but despite all odds, our team didn’t let this happen. Working remotely from home, a colleague started to call around 50-80 new potential partner, googling everyone who could offer shipment,” says Dr Reddy’s release.
“As new partnerships take some time to be established, the team connected closely to look at flights with existing partners. However, another hurdle was that some countries closed their airports – so did our import location in the EU, which was critical for this launch. To find alternatives, the supply chain team worked closely together with quality and logistics to find ways to address the situation – working late nights and through the weekend, in an attempt to approve a new import site and let them manage the importation and sampling,” says the release.
src : itln.in